Outliers? [BE/BA News]

posted by mittyri  – Russia, 2022-12-02 23:52 (1298 d 07:28 ago) – Posting: # 23382
Views: 19,452

Hi Helmut,

❝ Three options.

  1. Hire a consultant with a SAS license.

  2. AFAIK, the FDA recalculates all studies. Cross fingers.

  3. Wait till someone publishes a paper about cross-validation. ;-)

I'll cross fingers to have that omitted from the final guidance (even if I do not plan to submit to FDA anything:-D; FDA guidelines are getting used to penetrate across the world).

❝ As an aside:

How to assess ‘outliers’ in RSABE?

the only one method I can recall is described by Mr.Schall with coauthors
But I know that your question is not trivial and deeper than that.

PS: what is wrong with the format of cited list?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
149 visitors (1 registered, 148 guests [including 25 identified bots]).
Forum time: 08:21 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5